BioCentury
ARTICLE | Clinical News

Berinert P: Phase III data

December 3, 2007 8:00 AM UTC

In the double-blind, international Phase III IMPACT trial in 125 patients, the higher of 2 doses of C1-INH (20 units/kg) met the primary endpoint of a significant reduction in time to onset of relief ...